Q4 2024 Guidance -- Expected revenue between $71 million and $72 million; expected non-GAAP operating expenses of $50.5 million to $51.5 million; expected non-GAAP EPS of $0.23 to $0.24.

Liquidia Corporation remains a Buy for risk-tolerant biotech investors, supported by strong Yutrepia launch metrics and ...

Discover the top 6 undervalued Energy Equipment & Services stocks for Thursday, January 08 based on AAII’s Stock Grades.

Explore the top 5 Sony Digital Cameras available on Amazon, offering users high end specs and features to offer excellent ...

Abbelight, a global leader and a pioneer in super-resolution microscopy end-to-end solutions, today announced a successful Series B financing round led by AVANT BIO, a growth equity firm focused on ...

From entertainment-led flagships to hyper-localized experiences and old-school clienteling, industry insiders share how ...

In January 2025, Wockhardt announced that ZAYNICH demonstrated unprecedented efficacy in a global, pivotal Phase III study ...